K-STREET TRACKER
FOLLOW THE MONEY INTO THE SWAMP
Every federal lobbying filing tagged with a public-company ticker — who is spending, which firms they hire, and which members trade right around the filing.
Filings tracked
19,882
thru 2026-05-08
Total reported $
$2.7B
disclosed lobbying
Distinct clients
2,220
paying companies
Tickers targeted
1,207
public companies
💸 Top Spending Clients
| # | Client | Filings | Total $ |
|---|---|---|---|
| 1 |  PFIZER INC.PFE | 47 | $46.8M |
| 2 |  GENERAL MOTORS COMPANYGM | 61 | $46.8M |
| 3 |  META PLATFORMS INC. AND VARIOUS SUBSIDIARIESMETA | 12 | $44.9M |
| 4 | VISA INC.V | 45 | $37.7M |
| 5 |  AMAZON.COM SERVICES LLCAMZN | 36 | $32.8M |
| 6 |  LOCKHEED MARTIN CORPORATIONLMT | 73 | $29.0M |
| 7 |  FEDEX CORPORATIONFDX | 69 | $27.8M |
| 8 |  ELI LILLY AND COMPANYLLY | 56 | $27.1M |
| 9 |  ALTRIA CLIENT SERVICES LLCMO | 142 | $25.2M |
| 10 |  AMGEN INCAMGN | 19 | $24.9M |
| 11 |  COMCAST CORPORATIONCMCSV | 179 | $24.7M |
| 12 |  MERCK & CO INCMRK | 14 | $24.0M |
| 13 |  SOUTHERN COMPANYSO | 53 | $23.9M |
| 14 |  GOOGLE CLIENT SERVICES LLCGOOGL | 79 | $22.6M |
| 15 |  APPLE INCAAPL | 9 | $22.1M |
| 16 |  T-MOBILE USA INC.TMUS | 121 | $21.0M |
| 17 |  UNITEDHEALTH GROUP INCUNH | 19 | $20.4M |
| 18 |  VERIZON COMMUNICATIONS INC AND VARIOUS SUBSIDIARIESVZ | 40 | $20.1M |
| 19 |  OCCIDENTAL PETROLEUM CORPORATIONOXY | 30 | $19.7M |
| 20 |  MICROSOFT CORPORATIONMSFT | 103 | $18.8M |
| 21 |  QUALCOMM INCORPORATEDQCOM | 40 | $17.2M |
| 22 |  GENERAL DYNAMICS CORPGD | 11 | $17.0M |
| 23 |  BOEING COMPANYBA | 23 | $16.9M |
| 24 | THE CIGNA GROUP AND SUBSIDIARIES (FORMERLY CIGNA CORPORATION AND SUBSIDIARIES)CI | 13 | $16.9M |
| 25 |  ORACLE CORPORATIONORCL | 58 | $16.7M |
🎯 Top Lobbied Tickers
| # | Ticker | Filings | Total $ |
|---|---|---|---|
| 1 | META Meta Platforms Inc. | 129 | $50.2M |
| 2 | PFE Pfizer Inc. | 87 | $48.6M |
| 3 | GM General Motors Company | 103 | $48.4M |
| 4 | V Visa Inc. | 46 | $37.7M |
| 5 | AMZN Amazon.com Inc. | 80 | $35.3M |
| 6 | LMT Lockheed Martin Corporation | 88 | $29.4M |
| 7 | FDX FedEx Corporation | 82 | $28.3M |
| 8 | LLY Eli Lilly and Company | 83 | $28.1M |
| 9 | AMGN Amgen Inc. | 95 | $28.0M |
| 10 | MRK Merck & Co. Inc. | 92 | $27.5M |
| 11 | AAPL Apple Inc. | 64 | $26.8M |
| 12 | GOOGL Alphabet Inc. Class A | 123 | $26.6M |
| 13 | MO | 164 | $26.2M |
| 14 | SO Southern Company | 108 | $26.1M |
| 15 | UNH UnitedHealth Group Inc. | 67 | $23.9M |
| 16 | VZ Verizon Communications Inc. | 116 | $23.8M |
| 17 | TMUS | 159 | $22.7M |
| 18 |  CHTR | 137 | $22.6M |
| 19 | GD General Dynamics Corporation | 127 | $22.5M |
| 20 |  TAT&T Inc. | 134 | $21.6M |
| 21 | ORCL Oracle Corporation | 132 | $20.6M |
| 22 | CMCSA Comcast Corporation | 141 | $20.4M |
| 23 | CI The Cigna Group | 64 | $19.9M |
| 24 | OXY Occidental Petroleum Corporation | 36 | $19.9M |
| 25 | MSFT Microsoft Corporation | 122 | $19.2M |
🆕 Filtered Filings · CVS
clear filters| Date | Ticker | Client | Registrant | Amount | Issue |
|---|---|---|---|---|---|
| 2026-04-20 | CVS | CVS HEALTH (AND SUBSIDIARIES) | CVS HEALTH (AND SUBSIDIARIES) | $3.3M | Issues related to organized retail crime. H.R. 2853/S. 1404, The Combatting Organized Retail Crime Act S. 2068 - The End Prescription Drug Ads Now Act H.R. 3789 - The Drug-price Transparency for Consumers Act of 2025 Issues related to retail pharmacy, drug pricing, and women's health. H.R. 3164 - The Ensuring Community Access to Pharmacist Services Act of 2025 S. 2426 - The Equitable Community Access to Pharmacist Services Act H.R. 5031, The Preserving Patient Access to Long-Term Care Pharmacies Act Issues related to corporate tax. H.R. 3010/S. 1785 - No Handouts for Drug Advertisement Act Issues related to Medicare Part D, Medicare Advantage, Medicaid, mental health, and telehealth. Issues related to pharmacy testing, vaccination, and treatment. Issues related to Accountable Care Organizations. Issues related to Medicare Shared Savings Program. Issues related to Medicaid. S. 882, The Patients Before Middlemen (PBM) Act S. 927, The Protecting Pharmacies in Medicaid Act S. 1105 |
| 2026-04-20 | CVS | CVS HEALTH INC | BOCKORNY GROUP, INC. | $100K | Issues relating to legislation and regulations affecting Pharmacy Benefit Managers. |
| 2026-04-20 | CVS | OAK STREET HEALTH D/B/A CVS HEALTH | BGR GOVERNMENT AFFAIRS | $60K | Provide strategic counsel and advocacy on issues impacting value-based primary care centers for Medicare beneficiaries generally, and Oak Street Healthspecifically |
| 2026-04-20 | CVS | CVS HEALTH (AND SUBSIDIARIES) | THEGROUP DC, LLC | $50K | Tracked issues related to pharmacy services, Medicare Advantage and other health issues Tracked issues related to pharmacy services and other health issues. |
| 2026-04-20 | CVS | CVS HEALTH | MICHAEL BEST STRATEGIES LLC | $40K | Issues related to retail pharmacies, insurance, and Medicare/Medicaid. Issues related to retail pharmacies, insurance, and Medicare/Medicaid. Issues related to retail pharmacies, insurance, and Medicare/Medicaid. Issues related to retail pharmacies, insurance, and Medicare/Medicaid. |
| 2026-04-20 | CVS | CVS HEALTH | ALSTON & BIRD LLP | $30K | Issues related to Pub. L. No. 119-21, One Big Beautiful Bill Act, PBM reform and drug pricing. |
| 2026-04-17 | CVS | CVS HEALTH | CONTINENTAL STRATEGY, LLC | $105K | facilitated meetings and discussions regarding the healthcare industry. |
| 2026-04-15 | CVS | CVS HEALTH (AND SUBSIDIARIES) | ALB SOLUTIONS | $70K | Health care policy issues. |
| 2026-04-15 | CVS | CVS HEALTH | KOUNTOUPES DENHAM CARR & REID, LLC | $60K | Issues related to pharmaceutical supply chains and patient access. Issues related to Medicare Part D, Medicare Advantage and Medicaid. |
| 2026-04-09 | CVS | CVS HEALTH | KLEIN/JOHNSON GROUP | $0 | |
| 2026-03-30 | CVS | CVS HEALTH | MICHAEL BEST STRATEGIES LLC | $0 | Issues related to retail pharmacies, insurance, and Medicare/Medicaid. Issues related to retail pharmacies, insurance, and Medicare/Medicaid. Issues related to retail pharmacies, insurance, and Medicare/Medicaid. Issues related to retail pharmacies, insurance, and Medicare/Medicaid. |
| 2026-01-20 | CVS | CVS HEALTH (AND SUBSIDIARIES) | CVS HEALTH (AND SUBSIDIARIES) | $2.3M | Issues related to retail pharmacy, drug pricing, and women's health. H.R. 3164 - The Ensuring Community Access to Pharmacist Services Act of 2025 S. 2426 - The Equitable Community Access to Pharmacist Services Act H.R. 5031, The Preserving Patient Access to Long-Term Care Pharmacies Act Issues related to corporate tax. H.R. 3010/S. 1785 - No Handouts for Drug Advertisement Act Issues related to Medicare Part D, Medicare Advantage, Medicaid, mental health, and telehealth. Issues related to pharmacy testing, vaccination, and treatment. Issues related to Accountable Care Organizations. Issues related to Medicare Shared Savings Program. Issues related to Medicaid. S. 882, The Patients Before Middlemen (PBM) Act S. 927, The Protecting Pharmacies in Medicaid Act S. 1105 - No Unreasonable Payments, Coding, Or Diagnoses for the Elderly Act S. 3345, The PBM Price Transparency and Accountability Act H.R. 4317, The Pharmacy Benefit Manager (PBM) Reform Act H.R. 4093, Apple to Apples Compariso |
| 2026-01-20 | CVS | CVS HEALTH INC | BOCKORNY GROUP, INC. | $105K | Issues relating to legislation and regulations affecting Pharmacy Benefit Managers. |
| 2026-01-20 | CVS | OAK STREET HEALTH D/B/A CVS HEALTH | BGR GOVERNMENT AFFAIRS | $60K | Provide strategic counsel and advocacy on issues impacting value-based primary care centers for Medicare beneficiaries generally, and Oak Street Healthspecifically |
| 2026-01-20 | CVS | CVS HEALTH | KLEIN/JOHNSON GROUP | $50K | Issues related to CVS Healths acquisition of Aetna; Issues related to competition and consumer protection in pharmaceutical supply chain. General education about the pharmacy benefit manager/pharmacy and insurance industry; issues related to PBMs, including insulin. Issues related to organized retail crime enforcement |
| 2026-01-20 | CVS | CVS HEALTH (AND SUBSIDIARIES) | THEGROUP DC, LLC | $50K | Tracked issues related to pharmacy services, Medicare Advantage and other health issues Tracked issues related to pharmacy services and other health issues. |
| 2026-01-20 | CVS | CVS HEALTH | ALSTON & BIRD LLP | $30K | Issues related to Pub. L. No. 119-21, One Big Beautiful Bill Act, PBM reform and drug pricing. |
| 2026-01-19 | CVS | CVS HEALTH | CONTINENTAL STRATEGY, LLC | $105K | facilitated meetings and discussions regarding the healthcare industry. |
| 2026-01-18 | CVS | CVS HEALTH (AND SUBSIDIARIES) | ALB SOLUTIONS | $50K | Health care policy issues. |
| 2026-01-15 | CVS | CVS HEALTH | KOUNTOUPES DENHAM CARR & REID, LLC | $60K | Issues related to pharmaceutical supply chains and patient access. Issues related to H.R. 3164, Ensuring Community Access to Pharmacist Services Act and S.2426, Equitable Community Access to Pharmacist Services Act. Issues related to Medicare Part D, Medicare Advantage and Medicaid. |
| 2026-01-15 | CVS | CVS HEALTH | KEEFE SINGISER PARTNERS, FKA KEEFE STRATEGIES LLC | $30K | Issues involving lowering the cost of healthcare and prescription drug prices; quality healthcare, patient outcomes, and healthcare delivery. Issues encompassing general education regarding the pharmacy benefit manager/pharmacy industry. Issues related to access and affordability of healthcare, prescription drugs, and generic drugs. |
| 2026-01-15 | CVS | CVS HEALTH | KEEFE STRATEGIES LLC (FKA KEEFE SINGISER PARTNERS) | $0 | Lowering the cost of health care and prescription drug prices, quality health care, patient outcomes, health care delivery, smoking cessation, and women's heart health. Lowering the cost of health care and prescription drug prices, quality health care, patient outcomes, health care delivery, smoking cessation, and women's heart health. |
| 2025-10-20 | CVS | CVS HEALTH (AND SUBSIDIARIES) | CVS HEALTH (AND SUBSIDIARIES) | $2.1M | Issues related to retail pharmacy, drug pricing, and women's health. H.R. 3164 - The Ensuring Community Access to Pharmacist Services Act of 2025 S. 2426 - The Equitable Community Access to Pharmacist Services Act P.L. 119-21 - The One Big, Beautiful Bill Act - issues related to retail pharmacy Issues related to corporate tax. P.L. 119-21 - The One Big, Beautiful Bill Act H.R. 3010/S. 1785 - No Handouts for Drug Advertisement Act Issues related to Medicare Part D, Medicare Advantage, Medicaid, mental health, and telehealth. Issues related to pharmacy testing, vaccination, and treatment. Issues related to Accountable Care Organizations. Issues related to Medicare Shared Savings Program. Issues related to Medicaid. S. 882, The Patients Before Middlemen (PBM) Act S. 927, The Protecting Pharmacies in Medicaid Act S. 1105 - No Unreasonable Payments, Coding, Or Diagnoses for the Elderly Act P.L. 119-21 - The One Big, Beautiful Bill Act - - issues related to Medicaid and PBMs H.R. 4317, T |
| 2025-10-20 | CVS | CVS HEALTH INC | BOCKORNY GROUP, INC. | $105K | Issues relating to legislation and regulations affecting Pharmacy Benefit Managers. |
| 2025-10-20 | CVS | CVS HEALTH | CONTINENTAL STRATEGY, LLC | $105K | facilitated meetings and discussions regarding the healthcare industry. |
| 2025-10-20 | CVS | OAK STREET HEALTH D/B/A CVS HEALTH | BGR GOVERNMENT AFFAIRS | $60K | Provide strategic counsel and advocacy on issues impacting value-based primary care centers for Medicare beneficiaries generally, and Oak Street Healthspecifically |
| 2025-10-20 | CVS | CVS HEALTH (AND SUBSIDIARIES) | ALB SOLUTIONS | $50K | Health care policy issues. |
| 2025-10-20 | CVS | CVS HEALTH | KLEIN/JOHNSON GROUP | $50K | Issues related to CVS Healths acquisition of Aetna; Issues related to competition and consumer protection in pharmaceutical supply chain. General education about the pharmacy benefit manager/pharmacy and insurance industry; issues related to PBMs, including insulin. Issues related to organized retail crime enforcement |
| 2025-10-20 | CVS | CVS HEALTH (AND SUBSIDIARIES) | THEGROUP DC, LLC | $50K | Tracked issues related to pharmacy services, Medicare Advantage and other health issues Tracked issues related to pharmacy services and other health issues. |
| 2025-10-20 | CVS | CVS HEALTH | ALSTON & BIRD LLP | $30K | Issues related to Pub. L. No. 119-21, One Big Beautiful Bill Act, PBM reform and drug pricing. |
| 2025-10-15 | CVS | CVS HEALTH | KEEFE SINGISER PARTNERS, FKA KEEFE STRATEGIES LLC | $30K | Issues involving lowering the cost of healthcare and prescription drug prices; quality healthcare, patient outcomes, and healthcare delivery. Issues encompassing general education regarding the pharmacy benefit manager/pharmacy industry. Issues related to access and affordability of healthcare, prescription drugs, and generic drugs. |
| 2025-10-14 | CVS | CVS HEALTH | KOUNTOUPES DENHAM CARR & REID, LLC | $60K | Issues related to pharmaceutical supply chains and patient access. Issues related to H.R. 3164, Ensuring Community Access to Pharmacist Services Act and S.2426, Equitable Community Access to Pharmacist Services Act. Issues related to Medicare Part D, Medicare Advantage and Medicaid. Issues related to employer, small group, and individual insurance markets. Issues related to telehealth and remote patient monitoring. |
| 2025-07-21 | CVS | CVS HEALTH (AND SUBSIDIARIES) | CVS HEALTH (AND SUBSIDIARIES) | $1.8M | Issues related to retail pharmacy, drug pricing, and women's health. H.R. 3164 - The Ensuring Community Access to Pharmacist Services Act of 2025 P.L. 119-21 - The One Big, Beautiful Bill Act - issues related to retail pharmacy Issues related to corporate tax. P.L. 119-21 - The One Big, Beautiful Bill Act H.R. 3010/S. 1785 - No Handouts for Drug Advertisement Act Issues related to Medicare Part D, Medicare Advantage, Medicaid, mental health, and telehealth. Issues related to pharmacy testing, vaccination, and treatment. Issues related to Accountable Care Organizations. Issues related to Medicare Shared Savings Program. Issues related to Medicaid. S. 882, The Patients Before Middlemen (PBM) Act S. 927, The Protecting Pharmacies in Medicaid Act H.Con.Res.14 - Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034. S.Con.Res.7 - An original concurrent resolution s |
| 2025-07-21 | CVS | CVS HEALTH INC | BOCKORNY GROUP, INC. | $105K | Issues relating to legislation and regulations affecting Pharmacy Benefit Managers. |
| 2025-07-21 | CVS | OAK STREET HEALTH D/B/A CVS HEALTH | BGR GOVERNMENT AFFAIRS | $60K | Provide strategic counsel and advocacy on issues impacting value-based primary care centers for Medicare beneficiaries generally, and Oak Street Healthspecifically |
| 2025-07-21 | CVS | CVS HEALTH | KLEIN/JOHNSON GROUP | $50K | Issues related to CVS Healths acquisition of Aetna; Issues related to competition and consumer protection in pharmaceutical supply chain. General education about the pharmacy benefit manager/pharmacy and insurance industry; issues related to PBMs, including insulin. Issues related to organized retail crime enforcement |
| 2025-07-21 | CVS | CVS HEALTH (AND SUBSIDIARIES) | THEGROUP DC, LLC | $50K | Tracked issues related to pharmacy services, Medicare Advantage and other health issues |
| 2025-07-21 | CVS | CVS HEALTH | ALSTON & BIRD LLP | $40K | Issues related to the implementation of health care reform and issues related to PBMs and drug pricing. |
| 2025-07-18 | CVS | CVS HEALTH | CONTINENTAL STRATEGY, LLC | $105K | facilitated meetings and discussions regarding the healthcare industry. |
| 2025-07-18 | CVS | CVS HEALTH | KEEFE SINGISER PARTNERS, FKA KEEFE STRATEGIES LLC | $25K | Issues involving lowering the cost of healthcare and prescription drug prices; quality healthcare, patient outcomes, and healthcare delivery. Issues encompassing general education regarding the pharmacy benefit manager/pharmacy industry. Issues related to access and affordability of healthcare, prescription drugs, and generic drugs. |
| 2025-07-16 | CVS | CVS HEALTH | KOUNTOUPES DENHAM CARR & REID, LLC | $60K | Issues related to pharmaceutical supply chains and patient access. Issues related to Medicare Part D, Medicare Advantage and Medicaid. Issues related to employer, small group, and individual insurance markets. Issues related to telehealth and remote patient monitoring. |
| 2025-07-16 | CVS | CVS HEALTH (AND SUBSIDIARIES) | ALB SOLUTIONS | $50K | Health care policy issues. |
| 2025-05-07 | CVS | CVS HEALTH | CONTINENTAL STRATEGY, LLC | $50K | facilitated meetings and discussions regarding the healthcare industry. |
| 2025-04-24 | CVS | CVS HEALTH | CONTINENTAL STRATEGY, LLC | $0 | monitor legislation and regulatory developments and facilitate meetings and discussions regarding the healthcare industry. |
| 2025-04-21 | CVS | CVS HEALTH (AND SUBSIDIARIES) | CVS HEALTH (AND SUBSIDIARIES) | $3.5M | Issues related to retail pharmacy, drug pricing, and women's health. Issues related to corporate tax. Issues related to Medicare Part D, Medicare Advantage, Medicaid, mental health, and telehealth. Issues related to pharmacy testing, vaccination, and treatment. Issues related to Accountable Care Organizations. Issues related to Medicare Shared Savings Program. S. 882, the Patients Before Middlemen (PBM) Act S. 927, the Protecting Pharmacies in Medicaid Act H.R.1968 - Full-Year Continuing Appropriations and Extensions Act, 2025 H.Con.Res.14 - Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034. S.Con.Res.7 - An original concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034 Issues related to employer, small group |
| 2025-04-21 | CVS | OAK STREET HEALTH D/B/A CVS HEALTH | BGR GOVERNMENT AFFAIRS | $60K | Provide strategic counsel and advocacy on issues impacting value-based primary care centers for Medicare beneficiaries generally, and Oak Street Healthspecifically |
| 2025-04-21 | CVS | CVS HEALTH | KLEIN/JOHNSON GROUP | $50K | Issues related to CVS Healths acquisition of Aetna; Issues related to competition and consumer protection in pharmaceutical supply chain. General education about the pharmacy benefit manager/pharmacy and insurance industry; issues related to PBMs, including insulin. Issues related to organized retail crime enforcement |
| 2025-04-21 | CVS | CVS HEALTH (AND SUBSIDIARIES) | THEGROUP DC, LLC | $50K | Tracked issues related to pharmacy services and other health issues Tracked issues related to pharmacy services and other health issues |
| 2025-04-21 | CVS | CVS HEALTH INC | BOCKORNY GROUP, INC. | $40K | Issues relating to legislation and regulations affecting Pharmacy Benefit Managers. |
| 2025-04-21 | CVS | CVS HEALTH | ALSTON & BIRD LLP | $30K | Issues related to the implementation of health care reform and issues related to PBMs and drug pricing. |
| 2025-04-18 | CVS | CVS HEALTH (AND SUBSIDIARIES) | ALB SOLUTIONS | $50K | Health care policy issues. |
| 2025-04-14 | CVS | CVS HEALTH | KOUNTOUPES DENHAM CARR & REID, LLC | $60K | Issues related to pharmaceutical supply chains. Issues related to Medicare Part D, Medicare Advantage and Medicaid. Issues related to employer, small group, and individual insurance markets. |
| 2025-04-10 | CVS | CVS HEALTH | KEEFE SINGISER PARTNERS, FKA KEEFE STRATEGIES LLC | $25K | Issues involving lowering the cost of healthcare and prescription drug prices; quality healthcare, patient outcomes, and healthcare delivery. Issues encompassing general education regarding the pharmacy benefit manager/pharmacy industry. Issues related to access and affordability of healthcare, prescription drugs, and generic drugs. |
| 2025-03-07 | CVS | CVS HEALTH (AND SUBSIDIARIES) | THEGROUP DC, LLC | $0 | Issues related to pharmacy services and other health issues. Issues related to pharmacy services and other health issues. |
| 2025-02-19 | CVS | CVS HEALTH INC | BOCKORNY GROUP, INC. | $0 | Pharmacy |
| 2025-01-21 | CVS | CVS HEALTH (AND SUBSIDIARIES) | CVS HEALTH (AND SUBSIDIARIES) | $2.0M | Issues related to retail pharmacy, drug pricing, and women's health. H.R. 1770, The Equitable Community Access to Pharmacist Services Act S. 2477, The Equitable Community Access to Pharmacist Services Act Issues related to the corporate tax rate. Issues related to Medicare Part D, Medicare Advantage, Medicaid, mental health, and telehealth. Issues related to COVID testing, vaccination, and treatment. Issues related to Accountable Care Organizations. Issues related to Medicare Shared Savings Program. S. 1339 - Pharmacy Benefit Manager Reform Act of 2023 S. 1967 - Patients Before Middlemen Act of 2023 S. 2973 - Modernizing and Ensuring PBM Accountability (MEPA) Act S. 3430 - Better Mental Health Care, Lower-Cost Drugs, and Extenders Act H.R. 2679 - Pharmacy Benefit Manager Accountability Act of 2023 H.R. 3285 - Fairness for Patient Medications Act H.R. 1613 - Drug Price Transparency in Medicaid Act of 2023 H.R. 3561 - Promoting Access to Treatments and Increasing Extremely Needed Tra |
| 2025-01-21 | CVS | CVS HEALTH | KLEIN/JOHNSON GROUP | $70K | Issues related to CVS Healths acquisition of Aetna; Issues related to competition and consumer protection in pharmaceutical supply chain. General education about the pharmacy benefit manager/pharmacy and insurance industry; issues related to PBMs, including insulin. Issues related to organized retail crime enforcement. |
| 2025-01-21 | CVS | CVS HEALTH | ALSTON & BIRD LLP | $70K | Issues related to the implementation of health care reform and issues related to PBMs and drug pricing. |
| 2025-01-21 | CVS | CVS HEALTH (AND SUBSIDIARIES) | ALB SOLUTIONS | $50K | Health care policy issues. |
| 2025-01-20 | CVS | OAK STREET HEALTH D/B/A CVS HEALTH | BGR GOVERNMENT AFFAIRS | $60K | Provide strategic counsel and advocacy on issues impacting value-based primary care centers for Medicare beneficiaries generally, and Oak Street Health specifically |
| 2025-01-20 | CVS | CVS HEALTH | KEEFE SINGISER PARTNERS, FKA KEEFE STRATEGIES LLC | $15K | Issues involving lowering the cost of healthcare and prescription drug prices; quality healthcare, patient outcomes, and healthcare delivery. Issues encompassing general education regarding the pharmacy benefit manager/pharmacy industry. Issues related to access and affordability of healthcare, prescription drugs, and generic drugs. |